Clinical Trials Logo

Kidney Calculi clinical trials

View clinical trials related to Kidney Calculi.

Filter by:
  • Withdrawn  
  • Page 1 ·  Next »

NCT ID: NCT06138327 Withdrawn - Kidney Stone Clinical Trials

A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria

Start date: September 26, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to test the safety of BMN 255 and to learn about the effect BMN 255 has on you and your hyperoxaluria associated with NAFLD, and compare these effects with a placebo. The primary safety objective of the study is to assess the safety and tolerability of daily oral doses of BMN 255 in adult participants with NAFLD and hyperoxaluria. The primary efficacy objective of the study is to assess 24-hour urine oxalate levels (24-hour urine collection corrected for BSA) following daily oral doses of BMN 255 in adult participants with NAFLD and hyperoxaluria.

NCT ID: NCT05201456 Withdrawn - Urolithiasis Clinical Trials

LithoVue Elite Registry

LVE
Start date: April 1, 2023
Phase:
Study type: Observational [Patient Registry]

To obtain postmarket safety and efficacy data on Boston Scientific LithoVueâ„¢ Elite System.

NCT ID: NCT04727606 Withdrawn - Kidney Stone Clinical Trials

Research Project: Pilot Study on Oral Urea Use in Patients at High Risk of Kidney Stone Recurrence

Ure-Na
Start date: January 15, 2023
Phase: Phase 2
Study type: Interventional

In clinical practice, many patients are not able to modify their habits to achieve a high level of diuresis and fluid intake and therefore are at an elevated risk for stone recurrence. The investigators think that Ure-Na (osmotic agent) taking could help to increase urine volume and decrease urine concentration, which would be of benefit in the prevention of kidney stones.

NCT ID: NCT04545528 Withdrawn - Kidney Stone Clinical Trials

The Impact of Nutritional Service in the Stone Clinic on the Patient Urine Collection Results

NUT1
Start date: October 1, 2021
Phase:
Study type: Observational

Kidney stone disease has become a common phenomenon in the US and Europe with a growing incidence of about 10%. Life style and dietary changes have a cardinal part in kidney stone prevention. Therefore it was only natural to determine the impact of the addition of a nutritionist to a stone clinic run by a urologist and a nephrologist.

NCT ID: NCT04438551 Withdrawn - Kidney Stone Clinical Trials

Software Application for Low-Sodium Diet Trial (SALT)

Start date: February 12, 2021
Phase: N/A
Study type: Interventional

This a single-center prospective randomized controlled trial. Subjects will be assigned to the standard of care dietary recommendations for a low sodium diet (LSD) vs. the standard of care dietary recommendations for a low sodium diet plus a mobile application that analyzes sodium content of shopping lists that are created prior to shopping trips to the grocery store over an 8-week study period. An initial pilot phase will be done to ensure adequate percentage of subjects are completing the study in the intervention group and that adequate data is being collected.

NCT ID: NCT03714477 Withdrawn - Hypertension Clinical Trials

A Study to Investigate the Effect of Extracorporeal Shockwave Lithotripsy on Hypertension

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

Having the advantages of being minimally invasive and simple, extracorporeal shock wave lithotripsy (SWL) remains one of the treatment options for renal stones less than 2cm. Although SWL is the most minimally invasive surgical approach for stone, there are still some concern about its short and long term side effect. While, there are some evidences that SWL might lead to increase in new onset hypertension, investigator's recent study suggested it might also cause worsening of blood pressure control in patient with known hypertension. Therefore, further studies are needed to confirm the initial finding. This study recruits patients who have hypertension and are currently diagnosed to have renal stone and planned for SWL, in order to to investigate the effect of SWL on blood pressure control. After informed consent and background information have been obtained, patients will be randomized to either have routine SWL (treatment arm) or 6 months later (control arm). Group 1 patients will have blood pressure monitored for one day at home by an handy automated blood pressure measuring machine before SWL and 6 months after SWL. Group 2 patients will have blood pressure monitoring immediately and then 6 months later, just prior to the SWL.

NCT ID: NCT03638336 Withdrawn - Lithiasis, Urinary Clinical Trials

Evaluation of the Performance of a Robotic Flexible Ureteroscopy (ILY) in Laser Treatment of Nephrolithiasis

EASILY
Start date: October 2018
Phase: N/A
Study type: Interventional

In this pilot study, we wish to evaluate the performance of a robotic flexible ureteorscopy (ILY) in the treatment of nephrolithiasis in the superior excretory system

NCT ID: NCT03608098 Withdrawn - Kidney Stone Clinical Trials

Long Pulse Versus Short Pulse Laser Dusting for Renal Stones

Start date: May 2019
Phase: N/A
Study type: Interventional

The purpose of this research study is to compare how well two treatments work for removing kidney stones. The two study groups include ureteroscopy with long/short pulse lithotripsy to remove kidney stones. Both of these options are considered standard of care and are used currently in surgery.

NCT ID: NCT03549611 Withdrawn - Pain, Postoperative Clinical Trials

Pre-induction Analgesia: Multimodel Regimen vs Aceteminophen for Post Ureteroscopy Pain

MMPITR
Start date: August 1, 2018
Phase: Phase 4
Study type: Interventional

Adult patients with kidney stones undergoing surgical intervention with ureteroscopy with laser lithotripsy will be randomized to receive one of two different regimens of oral medications administered prior to induction of general anesthesia. Postoperatively, patients will receive automated daily text messages to assess pain and opioid consumption and subsequently determine which which treatment regimen is superior.

NCT ID: NCT03058614 Withdrawn - Ultrasonography Clinical Trials

Contrast-enhanced Ultrasound Versus CT Scan for Kidney Stone Patient Management

CEUS
Start date: June 30, 2017
Phase: Phase 2
Study type: Interventional

This study will be a randomized controlled study comparing the use of two clinical management strategies in nephrostomy tube management following percutaneous nephrolithotomy (PCNL). The first strategy entails using contrast-enhanced ultrasound (CEUS) to evaluate the renal collecting system (1). This is a new imaging approach applying ultrasound machines with special software in combination with intraluminal ultrasound contrast agent (Lumason) injection, which is an FDA-approved ultrasound contrast agent (2). The second strategy is a nephrostomy tube capping trial combined with low dose non-contrast computed tomography (CT) scan, one of the most frequently utilized clinical management strategies currently used in clinical practice (3).